Transcription of Ipca Laboratories Ltd.
{{id}} {{{paragraph}}}
Ipca Laboratories PresentationJune 2018 Company OverviewIncorporation:1949 Present Management :Since 1975 Total income F. Y. 2017-18:` Crs / US$ 505 MnExports F. Y. 2017-18:` Crs / US$ 243 MnExports F. Y. 2017-18:` Crs / US$ 243 MnNumber of Employees:13,294 including 6131in marketing and distributionBusiness Model:Fully integrated pharmaceuticalcompany producing Brandedand Generics Formulations,APIs and IntermediatesFive Years Highlights2013-14 2014-15 2015-16 2016-17 2017-18 Domestic Income ( ` Crs )1, , , , , Income (US $ Mn) Income ( ` Crs )2, , , , , Income ( ` Crs )2, , , , , Income (US $ Mn) Income ( ` Crs )3, , , , , Income (US $ Mn) Profit After Tax ( ` Crs ) Profit After Tax (US $ Mn)
Manufacturing Facilities Formulations Location Dosage Form Approvals / Inspections Athal, Silvassa Tablets & Capsules UK-MHRA, TGA-Australia, MCC-South Africa,
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}